Table 3.
Usability of diagnostic tests for cardiac sarcoidosis
| Sensitivity% | Specificity% | PPV% | NPV% | p-value | |
| ECG | 92 | 53 | 44 | 94 | <0.05 |
| Exercise test | 67 | 90 | 75 | 86 | <0.01 |
| Holter monitoring | 82 | 50 | 41 | 87 | 0.14 |
| NT-pro-BNP | 78 | 67 | 58 | 83 | <0.05 |
| TTE | 58 | 93 | 78 | 84 | <0.01 |
| CMR | 100 | 100 | 100 | 100 | <0.0001 |
| NT-pro-BNP and ECG (both pathologic) | 78 | 93 | 87 | 87 | <0.001 |
ECG=electrocardiogram, CMR=cardiovascular magnetic resonance, TTE=transthoracic echocardiogram, NT-pro-BNP=N-terminal pro B-type natriuretic peptide, PPV=positive predictive value, NPV=negative predictive value.